Research Peptides in the UAE
COA-verified peptide supply in Dubai with same-day delivery. HPLC-tested research-grade compounds from a UAE-based supplier with published third-party purity verification.
Update History ▾
Initial publication
Remy Peptides is a Dubai-based research peptide supplier offering HPLC-verified compounds with published Certificates of Analysis. Current product: Retatrutide pens (30mg and 20mg prefilled Pen) at 99.262% purity, independently verified by Janoshik Analytical. Same-day delivery in Dubai (order by 4 PM), next-day across the UAE (order by 12 PM). Priced at AED 1,800/pen, with volume tiers from AED 1,500/pen (5+ pack).
Why UAE Researchers Choose Remy Peptides
The UAE peptide market includes dozens of suppliers, but most lack the transparency that rigorous research demands. The difference between Remy Peptides and other UAE peptide suppliers comes down to three factors: published third-party COAs, prefilled pen formats that eliminate reconstitution variables, and temperature-controlled delivery designed for the UAE climate.
- Published COAs: Every batch ships with a Certificate of Analysis from Janoshik Analytical, an independent third-party laboratory. Current batches: 30mg pen RETP002 at 99.262%, 20mg pen RET-20-C-2604-001 at 99.841%, vial line RET-20-V-2604-001 at 99.741% HPLC purity—not generic “99%+” claims, but specific, verifiable numbers. The full COAs are published on our website before purchase; the Peptide COA Guide explains how to read the fields.
- Prefilled pen format: Traditional lyophilised powder vials require manual reconstitution—introducing contamination risk and dosing variability. Our Pen format delivers precise 0.1mg-per-click dosing with no preparation required.
- Cold-chain delivery: All peptide orders in the UAE ship in temperature-controlled packaging. Dubai deliveries arrive same day (order by 4 PM). This is critical during UAE summer months when ambient temperatures exceed 45°C and peptide stability is at risk. For detailed guidance on handling and storage after receipt, see our peptide stability and storage guide.
What Peptides Are Available in Dubai?
Remy Peptides currently specialises in Retatrutide (LY-3437943), the triple-agonist peptide from Eli Lilly that simultaneously activates GLP-1, GIP, and glucagon receptors. In Phase 2 clinical trials published in the New England Journal of Medicine, Retatrutide demonstrated 24.2% mean body weight reduction—the highest efficacy reported for any investigational obesity compound to date.
| Product | Format | Content | Purity | Price (1 pen) |
|---|---|---|---|---|
| Retatrutide 30mg Pen | Prefilled Pen | 300 clicks × 0.1mg | 99.262% | AED 1,800 |
| Retatrutide Pen 20mg | Prefilled Pen | 300 clicks | ≥98% | AED 1,200 |
Volume pricing: AED 1,650/pen (2-pack) and AED 1,500/pen (5+ pack) for the 30mg format. For bulk research procurement or institutional orders, contact us via Telegram at @RemyPeptides.
Peptide Research in the UAE — Regulatory Context
Research peptides for in-vitro laboratory use are available in the UAE under specific conditions. All Remy Peptides products are labelled “For Research Use Only” in accordance with UAE Ministry of Health and Prevention (MoHAP) guidelines. These materials are not intended for human or veterinary administration. For a Dubai-specific, source-led reading of how that framework is applied in practice, see our Dubai legality brief.
The UAE has emerged as a growing hub for metabolic and obesity research, driven by one of the highest regional obesity prevalence rates (exceeding 30% of the adult population). Research institutions across Dubai, Abu Dhabi, and Sharjah are actively investigating next-generation GLP-1 receptor agonists, dual-agonist compounds, and triple-agonist peptides like Retatrutide. For a full overview of the UAE obesity research landscape, see our UAE obesity statistics and GLP-1 landscape analysis.
How to Evaluate a Peptide Supplier in the UAE
Not all peptide suppliers in Dubai and the UAE maintain the same quality standards. Researchers who want a current Dubai peptide catalogue before comparing suppliers can review the available compounds first. When evaluating a UAE peptide supplier, researchers should verify the following before ordering:
- Third-party COA: The Certificate of Analysis should come from an independent laboratory (not the supplier’s own in-house testing). Look for named labs like Janoshik Analytical with specific HPLC purity values, not rounded “99%+” claims.
- Published batch data: Reputable suppliers publish their COAs publicly, not just on request. If a supplier only provides a COA after payment, that’s a red flag.
- Product format: Prefilled pens reduce contamination risk compared to powder vials that require reconstitution. For UAE-based research, the elimination of manual preparation steps is especially valuable.
- Cold-chain logistics: In a country where summer temperatures regularly exceed 45°C, temperature-controlled delivery is not optional—it’s a baseline requirement for peptide integrity.
- Compliance labelling: All research peptides should be clearly labelled “For Research Use Only” with appropriate disclaimers.
Peptide Categories in UAE Research
UAE-based research laboratories work with several categories of peptides, each with different applications in metabolic, regenerative, and cellular biology research.
GLP-1 Receptor Agonists
GLP-1 (glucagon-like peptide-1) receptor agonists are the most widely studied class of metabolic peptides. Approved compounds include semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro). Retatrutide extends this class by adding GIP and glucagon receptor activity. Our GLP-1 medications in the UAE article covers availability and cost data for approved compounds.
Triple-Agonist Peptides
Retatrutide is the most advanced triple-agonist peptide in clinical development, simultaneously targeting GLP-1, GIP, and glucagon receptors. Researchers looking to buy retatrutide in Dubai can source COA-verified pens locally. This three-receptor mechanism produced 24.2% weight reduction in Phase 2 data—exceeding the results of both single-agonist (semaglutide, ~15%) and dual-agonist (tirzepatide, ~22.5%) compounds. For a detailed mechanism breakdown, see our triple-agonist pathway analysis.
Regenerative & Tissue-Repair Peptides
BPC-157, GHK-Cu, and related peptides are studied for their roles in tissue repair, wound healing, and cellular regeneration. While Remy Peptides currently specialises in metabolic peptides (Retatrutide), the UAE research market includes significant activity in regenerative peptide studies. For a focused breakdown of copper peptide evidence, see our GHK-Cu Dubai skin protocol research guide alongside our peptide trends in the UAE for 2026.
Metabolic & Exercise-Mimetic Compounds
Beyond GLP-1 agonists, UAE metabolic research includes AMPK-pathway activators such as AICAR (acadesine), which promotes fat oxidation and glucose uptake independently of physical activity. These compounds are studied alongside incretin-based peptides to map complementary metabolic pathways.
Neuroprotective Peptide Complexes
Neuroprotective peptides represent an emerging research category in the UAE. Cerebrolysin, a porcine brain-derived peptide complex, has been investigated in clinical settings for neurodegenerative conditions and traumatic brain injury, with data on neurotrophic factor modulation and synaptic plasticity.
Peptide Delivery Across the UAE
Remy Peptides provides temperature-controlled delivery for all research peptide orders across the United Arab Emirates.
- Dubai: Same-day delivery (order by 4 PM) — all areas including DIFC, Downtown, JBR, JLT, Business Bay, Dubai Marina, and Dubai Hills
- Abu Dhabi: Next-day delivery (order by 12 PM)
- Sharjah: Next-day delivery (order by 12 PM)
- Ajman, RAK, UAQ, Fujairah: Next-day delivery (order by 12 PM)
All shipments use insulated, temperature-controlled packaging to maintain cold-chain integrity from dispatch to laboratory receipt. For order tracking or research enquiries, contact us via WhatsApp.
How Does Remy Compare to Other UAE Peptide Suppliers?
| Feature | Remy Peptides | Typical UAE Supplier |
|---|---|---|
| COA Source | Janoshik Analytical (independent) | In-house or unspecified |
| Purity Verification | 99.262% HPLC (published) | “99%+” (unverified) |
| Format | Prefilled Pen | Lyophilised powder vials |
| Dosing | 0.1mg per click (precise) | Manual syringe measurement |
| Dubai Delivery | Same day (order by 4 PM) | Same-day or next-day |
| Research Library | 48 articles | Product pages only |
| Compliance | “Research Use Only” labelling | Varies |
Our Research Standards
This article cites peer-reviewed studies, FDA filings, and ClinicalTrials.gov data. All claims are cross-referenced against primary sources. We update articles when new trial data or regulatory decisions are published. Read our editorial policy →
- Jastreboff AM, et al. Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial. N Engl J Med. 2023;389(6):514-526.
- Janoshik Analytical — Certificate of Analysis, Batch RETP002. HPLC purity: 99.262%.
- UAE Ministry of Health and Prevention (MoHAP) Circular 17/2022.
- Eli Lilly. TRIUMPH Clinical Trial Program for Retatrutide. ClinicalTrials.gov.
- WHO Obesity Data — United Arab Emirates Country Profile.